Gary S. Hogge, D.V.M., M.S. Ph.D.

Gary S. Hogge, D.V.M., M.S. Ph.D.

Former SVP Clinical and Medical AffairsatLineage Cell Therapeutics· In the 2023 proxy

Pay in FY2023

Gary S. Hogge, D.V.M., M.S. Ph.D. was paid $860.6K in FY2023 (Dec).

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Lineage Cell Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Lineage Cell TherapeuticsPublic company · 3 yr
    • Former SVP Clinical and Medical Affairs2023 – Present · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?